Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL ELECTROTHERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL XX SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL ELECTROTHERAPY MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 INSTALLED BASE DATA
15 VALUE CHAIN ANALYSIS
16 HEALTHCARE ECONOMY
16.1 HEALTHCARE EXPENDITURE
16.2 CAPITAL EXPENDITURE
16.3 CAPEX TRENDS
16.4 CAPEX ALLOCATION
16.5 FUNDING SOURCES
16.6 INDUSTRY BENCHMARKS
16.7 GDP RATION IN OVERALL GDP
16.8 HEALTHCARE SYSTEM STRUCTURE
16.9 GOVERNMENT POLICIES
16.1 ECONOMIC DEVELOPMENT
17 GLOBAL ELECTROTHERAPY MARKET, BY THERAPY TYPE
17.1 OVERVIEW
17.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
17.2.1 BY FREQUENCY
17.2.1.1. HIGH FREQUENCY (90 – 130 HZ)
17.2.1.2. LOWER FREQUENCY (2 – 5 HZ)
17.2.2 BY INDICATION
17.2.2.1. ARTHRITIS
17.2.2.2. FIBROMYALGIA
17.2.2.3. KNEE PAIN
17.2.2.4. BACK PAIN
17.2.2.5. NECK PAIN
17.2.2.6. DIABETIC NEUROPATHY
17.2.2.7. PELVIC PAIN FROM PERIODS OR ENDOMETRIOSIS
17.2.2.8. OTERS
17.3 HIGH VOLTAGE ELECTRICAL STIMULATION
17.3.1 BY INDICATION
17.3.1.1. ADHESIVE BURSITIS
17.3.1.2. WOUND HEALING
17.3.1.3. CERVICAL SPRAIN
17.3.1.4. DEGENERATIVE DISC
17.3.1.5. EPICONDYLITIS
17.3.1.6. SPRAIN
17.3.1.7. POST-OPERATIVE PAIN
17.3.1.8. OTHERS
17.4 THERAPEUTIC ULTRASOUND
17.4.1 BY TYPE
17.4.1.1. THERMAL
17.4.1.2. MECHANICAL
17.4.2 BY INDICATION
17.4.2.1. ACUTE INJURIES
17.4.2.2. CHRONIC INJURIES
17.5 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
17.5.1 BY INDICATION
17.5.1.1. INCONTINENCE
17.5.1.2. MUSCLE REHABILITATION
17.5.1.3. MUSCLE WEAKNESS
17.5.1.4. OTHERS
17.6 INFERENTIAL CURRENT (IFC)
17.6.1 BY INDICATION
17.6.1.1. MUSCLE SPASM
17.6.1.2. EDEMA
17.6.1.3. HEMATOMA
17.6.1.4. CHRONIC LIGAMENT LESION
17.6.1.5. RADICULOPATHY
17.6.1.6. STRESS INCONTINENCE
17.6.1.7. CHRONIC LIGAMENT LESION
17.6.1.8. OTHERS
17.7 SHOCK WAVE THERAPY
17.7.1 BY INDICATION
17.7.1.1. PAIN MANAGEMENT
17.7.1.2. ORTHOPEDICS
17.7.1.3. SPORTS MEDICINE
17.7.1.4. OTHERS
17.8 ELECTROACUPUNCTURE
17.8.1 BY TYPE
17.8.1.1. LOW FREQUENCY
17.8.1.2. HIGH FREQUENCY
17.8.2 BY INDICATION
17.8.2.1. ARTHRITIS
17.8.2.2. PAIN
17.8.2.3. STRESS
17.8.2.4. ADDICTION
17.8.2.5. TINNITUS
17.8.2.6. OTHERS
17.9 ELECTRICAL MUSCLE STIMULATION (EMS)
17.9.1 BY INDICATION
17.9.1.1. PHYSICAL REHABILITATION
17.9.1.2. WEIGHT LOSS
17.9.1.3. MUSCLE SPASM RELAXATION
17.9.1.4. ATROPHY
17.9.1.5. OTHERS
17.1 OTHERS
18 GLOBAL ELECTROTHERAPY MARKET, BY APPLICATION
18.1 OVERVIEW
18.2 ARTHRITIS
18.3 FIBROMYALGIA
18.4 PAIN MANAGEMENT
18.4.1 KNEE PAIN
18.4.2 BACK PAIN
18.4.3 NECK PAIN
18.4.4 OTHERS
18.5 DIABETIC NEUROPATHY
18.6 ADHESIVE BURSITIS
18.7 WOUND HEALING
18.8 CERVICAL SPRAIN
18.9 DEGENERATIVE DISC
18.1 EPICONDYLITIS
18.11 INCONTINENCE
18.12 MUSCLE REHABILITATION
18.13 MUSCLE WEAKNESS
18.14 ADDICTION
18.15 TINNITUS
18.16 OTHERS
19 GLOBAL ELECTROTHERAPY MARKET, BY END USER
19.1 OVERVIEW
19.2 HOSPITALS
19.2.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
19.2.2 HIGH VOLTAGE ELECTRICAL STIMULATION
19.2.3 THERAPEUTIC ULTRASOUND
19.2.4 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
19.2.5 INFERENTIAL CURRENT (IFC)
19.2.6 SHOCK WAVE THERAPY
19.2.7 ELECTROACUPUNCTURE
19.2.8 ELECTRICAL MUSCLE STIMULATION (EMS)
19.2.9 OTHERS
19.3 REHABILITATION CENTRES
19.3.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
19.3.2 HIGH VOLTAGE ELECTRICAL STIMULATION
19.3.3 THERAPEUTIC ULTRASOUND
19.3.4 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
19.3.5 INFERENTIAL CURRENT (IFC)
19.3.6 SHOCK WAVE THERAPY
19.3.7 ELECTROACUPUNCTURE
19.3.8 ELECTRICAL MUSCLE STIMULATION (EMS)
19.3.9 OTHERS
19.4 PHYSICAL THERAPY CLINICS
19.4.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
19.4.2 HIGH VOLTAGE ELECTRICAL STIMULATION
19.4.3 THERAPEUTIC ULTRASOUND
19.4.4 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
19.4.5 INFERENTIAL CURRENT (IFC)
19.4.6 SHOCK WAVE THERAPY
19.4.7 ELECTROACUPUNCTURE
19.4.8 ELECTRICAL MUSCLE STIMULATION (EMS)
19.4.9 OTHERS
19.5 SPECIALTY CLINICS
19.5.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
19.5.2 HIGH VOLTAGE ELECTRICAL STIMULATION
19.5.3 THERAPEUTIC ULTRASOUND
19.5.4 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
19.5.5 INFERENTIAL CURRENT (IFC)
19.5.6 SHOCK WAVE THERAPY
19.5.7 ELECTROACUPUNCTURE
19.5.8 ELECTRICAL MUSCLE STIMULATION (EMS)
19.5.9 OTHERS
19.6 SPA AND WELLNESS CENTERS
19.6.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
19.6.2 HIGH VOLTAGE ELECTRICAL STIMULATION
19.6.3 THERAPEUTIC ULTRASOUND
19.6.4 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
19.6.5 INFERENTIAL CURRENT (IFC)
19.6.6 SHOCK WAVE THERAPY
19.6.7 ELECTROACUPUNCTURE
19.6.8 ELECTRICAL MUSCLE STIMULATION (EMS)
19.6.9 OTHERS
19.7 SPORTS MEDICINE CLINICS
19.7.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
19.7.2 HIGH VOLTAGE ELECTRICAL STIMULATION
19.7.3 THERAPEUTIC ULTRASOUND
19.7.4 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
19.7.5 INFERENTIAL CURRENT (IFC)
19.7.6 SHOCK WAVE THERAPY
19.7.7 ELECTROACUPUNCTURE
19.7.8 ELECTRICAL MUSCLE STIMULATION (EMS)
19.7.9 OTHERS
19.8 AMBULATORY CENTERS
19.8.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
19.8.2 HIGH VOLTAGE ELECTRICAL STIMULATION
19.8.3 THERAPEUTIC ULTRASOUND
19.8.4 NEUROMUSCULAR ELECTRICAL STIMULATION (NMES)
19.8.5 INFERENTIAL CURRENT (IFC)
19.8.6 SHOCK WAVE THERAPY
19.8.7 ELECTROACUPUNCTURE
19.8.8 ELECTRICAL MUSCLE STIMULATION (EMS)
19.8.9 OTHERS
19.9 OTHERS
20 GLOBAL ELECTROTHERAPY MARKET, BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 DIRECT TENDER
20.3 RETAIL SALES
20.4 OTHERS
21 GLOBAL ELECTROTHERAPY MARKET, SWOT AND DBMR ANALYSIS
22 GLOBAL ELECTROTHERAPY MARKET, COMPANY LANDSCAPE
22.1 COMPANY SHARE ANALYSIS: GLOBAL
22.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
22.3 COMPANY SHARE ANALYSIS: EUROPE
22.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
22.5 MERGERS & ACQUISITIONS
22.6 NEW PRODUCT DEVELOPMENT & APPROVALS
22.7 EXPANSIONS
22.8 REGULATORY CHANGES
22.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
23 GLOBAL ELECTROTHERAPY MARKET, BY REGION
23.1 GLOBAL ELECTROTHERAPY MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
23.2 NORTH AMERICA
23.2.1 U.S.
23.2.2 CANADA
23.2.3 MEXICO
23.3 EUROPE
23.3.1 GERMANY
23.3.2 U.K.
23.3.3 ITALY
23.3.4 FRANCE
23.3.5 SPAIN
23.3.6 RUSSIA
23.3.7 SWITZERLAND
23.3.8 TURKEY
23.3.9 BELGIUM
23.3.10 NETHERLANDS
23.3.11 DENMARK
23.3.12 SWEDEN
23.3.13 POLAND
23.3.14 NORWAY
23.3.15 FINLAND
23.3.16 REST OF EUROPE
23.4 ASIA-PACIFIC
23.4.1 JAPAN
23.4.2 CHINA
23.4.3 SOUTH KOREA
23.4.4 INDIA
23.4.5 SINGAPORE
23.4.6 THAILAND
23.4.7 INDONESIA
23.4.8 MALAYSIA
23.4.9 PHILIPPINES
23.4.10 AUSTRALIA
23.4.11 NEW ZEALAND
23.4.12 VIETNAM
23.4.13 TAIWAN
23.4.14 REST OF ASIA-PACIFIC
23.5 SOUTH AMERICA
23.5.1 BRAZIL
23.5.2 ARGENTINA
23.5.3 REST OF SOUTH AMERICA
23.6 MIDDLE EAST AND AFRICA
23.6.1 SOUTH AFRICA
23.6.2 EGYPT
23.6.3 BAHRAIN
23.6.4 UNITED ARAB EMIRATES
23.6.5 KUWAIT
23.6.6 OMAN
23.6.7 QATAR
23.6.8 SAUDI ARABIA
23.6.9 REST OF MEA
23.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
24 GLOBAL ELECTROTHERAPY MARKET, COMPANY PROFILE
24.1 MEDTRONIC
24.1.1 COMPANY OVERVIEW
24.1.2 REVENUE ANALYSIS
24.1.3 GEOGRAPHIC PRESENCE
24.1.4 PRODUCT PORTFOLIO
24.1.5 RECENT DEVELOPMENTS
24.2 ABBOTT
24.2.1 COMPANY OVERVIEW
24.2.2 REVENUE ANALYSIS
24.2.3 GEOGRAPHIC PRESENCE
24.2.4 PRODUCT PORTFOLIO
24.2.5 RECENT DEVELOPMENTS
24.3 ZYNEX MEDICAL
24.3.1 COMPANY OVERVIEW
24.3.2 REVENUE ANALYSIS
24.3.3 GEOGRAPHIC PRESENCE
24.3.4 PRODUCT PORTFOLIO
24.3.5 RECENT DEVELOPMENTS
24.4 NEUROMETRIX, INC.
24.4.1 COMPANY OVERVIEW
24.4.2 REVENUE ANALYSIS
24.4.3 GEOGRAPHIC PRESENCE
24.4.4 PRODUCT PORTFOLIO
24.4.5 RECENT DEVELOPMENTS
24.5 DJO, LLC
24.5.1 COMPANY OVERVIEW
24.5.2 REVENUE ANALYSIS
24.5.3 GEOGRAPHIC PRESENCE
24.5.4 PRODUCT PORTFOLIO
24.5.5 RECENT DEVELOPMENTS
24.6 NEVRO CORP.
24.6.1 COMPANY OVERVIEW
24.6.2 REVENUE ANALYSIS
24.6.3 GEOGRAPHIC PRESENCE
24.6.4 PRODUCT PORTFOLIO
24.6.5 RECENT DEVELOPMENTS
24.7 OMRON HEALTHCARE, INC.
24.7.1 COMPANY OVERVIEW
24.7.2 REVENUE ANALYSIS
24.7.3 GEOGRAPHIC PRESENCE
24.7.4 PRODUCT PORTFOLIO
24.7.5 RECENT DEVELOPMENTS
24.8 WALGREEN CO
24.8.1 COMPANY OVERVIEW
24.8.2 REVENUE ANALYSIS
24.8.3 GEOGRAPHIC PRESENCE
24.8.4 PRODUCT PORTFOLIO
24.8.5 RECENT DEVELOPMENTS
24.9 BTL
24.9.1 COMPANY OVERVIEW
24.9.2 REVENUE ANALYSIS
24.9.3 GEOGRAPHIC PRESENCE
24.9.4 PRODUCT PORTFOLIO
24.9.5 RECENT DEVELOPMENTS
24.1 CHIRAG ELECTRONICS PVT. LTD
24.10.1 COMPANY OVERVIEW
24.10.2 REVENUE ANALYSIS
24.10.3 GEOGRAPHIC PRESENCE
24.10.4 PRODUCT PORTFOLIO
24.10.5 RECENT DEVELOPMENTS
24.11 EMS PHYSIO LTD.
24.11.1 COMPANY OVERVIEW
24.11.2 REVENUE ANALYSIS
24.11.3 GEOGRAPHIC PRESENCE
24.11.4 PRODUCT PORTFOLIO
24.11.5 RECENT DEVELOPMENTS
24.12 HMS MEDICAL SYSTEMS
24.12.1 COMPANY OVERVIEW
24.12.2 REVENUE ANALYSIS
24.12.3 GEOGRAPHIC PRESENCE
24.12.4 PRODUCT PORTFOLIO
24.12.5 RECENT DEVELOPMENTS
25 RELATED REPORTS
26 CONCLUSION
27 QUESTIONNAIRE
28 ABOUT DATA BRIDGE MARKET RESEARCH
